Companies / Florida / Longeveron

· rebuilt nightly from public records

Signal Sheet

Selling to Longeveron? Who to reach and why now

Headquartered in Miami, Florida, Longeveron is a publicly listed pharmaceutical preparations company. It raised $15.9M in Mar 2026 and its filings name 10 officers. Everything below links to the record it came from.

Listed company · Pharmaceutical Preparations · Florida

The easy button for new customers

Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.

Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.

SourceNew accounts that match what you offer, added as the signals land. The list never runs dry.
Reach outA first email written from why the account is hot, then a drip sequence that follows up until they reply. Sent from your own mailbox, with every open and reply tracked.
PursueAn AI-written plan built from your value proposition and the customer's compelling event: who to call, what to lead with, and the next step to win it. In early access.
Start your free trial →Tell it what you sell and where. Your list stays yours.

Who to reach

The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names

RoleContactSourceWhy they matter now
Executive OfficerStephen H. WillardSEC filing, Mar 2026Named officer in the filing; part of the buying group
Executive OfficerJoshua M. HareSEC filing, Mar 2026Named officer in the filing; part of the buying group
Executive OfficerLisa A. LocklearSEC filing, Mar 2026Named officer in the filing; part of the buying group
Executive OfficerNataliya AgafonovaSEC filing, Mar 2026Named officer in the filing; part of the buying group
Executive OfficerPaul LehrSEC filing, Mar 2026Named officer in the filing; part of the buying group
Executive OfficerDevin BlassSEC filing, Mar 2026Named officer in the filing; part of the buying group
Chief Technology OfficerRock SofferSEC filing, Mar 2026Technology and tooling decisions
Chief Technology OfficerUrsula UngaroSEC filing, Mar 2026Technology and tooling decisions
Chief Technology OfficerRoger Joseph HajjarSEC filing, Mar 2026Technology and tooling decisions
Chief Technology OfficerJr. George PalettaSEC filing, Mar 2026Technology and tooling decisions
For sellersWhy Longeveron is worth a call this quarterBuy Window: open · new leadership Nov 2026
Nov 1Nov 2026

New leadership

Officer or director change

New leadership
$15.9M

Raised

Equity raise reported to the SEC, Mar 2026. Money arrives before the spending plan does.

Capital
10officers

Named in filings

Each with a title and the filing that names them, so the first call goes to the right desk.

People
Track Longeveron with a free trial →Get the next signal the day it is filed or posted.
Email me the next Longeveron signalOne email when it files, raises, hires or posts a role. Watch up to 3 companies free, no password.

Why now

The most recent events first, refreshed every night. Each links to the record it came from.

WhenWhat happenedKindSource
Nov 1, 2026Officer or director changeNew leadershipSEC filing
Oct 7, 2026Officer or director changeNew leadershipSEC filing
Aug 17, 2026Officer or director changeNew leadershipSEC filing
Mar 11, 2026Raised $15.9M in equity from 7 investorsCapitalSEC filing

Reach Longeveron with emails that land

Lakewave finds the right people at Longeveron, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.

Try it on Longeveron with a free trial →

About Longeveron

HeadquartersMiami, Florida, per the filing address
Industry groupPharmaceutical Preparations
OwnershipListed company
Raise history$15.9M (Mar 2026)
Lakewave Rising22 · 2 kinds of evidence · rank in Florida after sign-up

Similar companies

Private-sector companies in the same industry group and state, ranked by Rising score.

Silo Pharma · 18Akari Therapeutics · 18Cadrenal Therapeutics · 8Jupiter Neurosciences · 4TuHURA BiosciencesSee all 5 with a free trial →

Questions people ask

Did Longeveron raise funding in 2026?

Yes. Longeveron reported a $15.9M equity raise to the SEC on Mar 11, 2026 with 7 investors.

Who runs Longeveron?

The company's SEC filing, Mar 2026 names Stephen H. Willard (Executive Officer) among its officers.

Where is Longeveron headquartered?

Miami, Florida, per the address on its SEC filing.

Know who is buying before the first callStart your free trial →

Know who is buying before the first call

Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.

Start your free trial

Compiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.